These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36286943)

  • 1. [Pregnancy in paroxysmal nocturnal hemoglobinuria: from survival to life].
    Vinogradova MA; Kulagin AD; Shmakov RG
    Ter Arkh; 2022 Aug; 94(7):859-864. PubMed ID: 36286943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
    Miyasaka N; Miura O; Kawaguchi T; Arima N; Morishita E; Usuki K; Morita Y; Nishiwaki K; Ninomiya H; Gotoh A; Imashuku S; Urabe A; Shichishima T; Nishimura J; Kanakura Y
    Int J Hematol; 2016 Jun; 103(6):703-12. PubMed ID: 26857155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nationwide study of eculizumab in paroxysmal nocturnal hemoglobinuria: Evaluation of treatment indications and outcomes.
    Schaap CCM; Heubel-Moenen FCJI; Nur E; Bartels M; van der Heijden OWH; de Jonge E; Preijers FWMB; Blijlevens NMA; Langemeijer SMC;
    Eur J Haematol; 2023 Jun; 110(6):648-658. PubMed ID: 36811247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab in Pregnant Patients with Paroxysmal Nocturnal Hemoglobinuria.
    Kelly RJ; Höchsmann B; Szer J; Kulasekararaj A; de Guibert S; Röth A; Weitz IC; Armstrong E; Risitano AM; Patriquin CJ; Terriou L; Muus P; Hill A; Turner MP; Schrezenmeier H; Peffault de Latour R
    N Engl J Med; 2015 Sep; 373(11):1032-9. PubMed ID: 26352814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.
    Martí-Carvajal AJ; Anand V; Cardona AF; Solà I
    Cochrane Database Syst Rev; 2014 Oct; (10):CD010340. PubMed ID: 25356860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the Management of Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Review.
    Zhang B; Chu R; Huang C; Song X; Wang J; Li L; Xu Y; Ma Y
    J Womens Health (Larchmt); 2024 Jan; 33(1):98-104. PubMed ID: 37917919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab in pregnancy: a narrative overview.
    Sarno L; Tufano A; Maruotti GM; Martinelli P; Balletta MM; Russo D
    J Nephrol; 2019 Feb; 32(1):17-25. PubMed ID: 30159857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of eculizumab treatment in patients with paroxysmal nocturnal hemoglobinuria with or without high disease activity: Real-world findings from the International Paroxysmal Nocturnal Hemoglobinuria Registry.
    Höchsmann B; de Fontbrune FS; Lee JW; Kulagin AD; Hillmen P; Wilson A; Marantz JL; Schrezenmeier H
    Eur J Haematol; 2022 Sep; 109(3):197-204. PubMed ID: 35390189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation.
    Alashkar F; Saner FH; Vance C; Schmücker U; Herich-Terhürne D; Dührsen U; Köninger A; Röth A
    Front Med (Lausanne); 2020; 7():543372. PubMed ID: 33102497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic Cell Transplantation for Paroxysmal Nocturnal Hemoglobinuria in the Age of Eculizumab.
    Cooper JP; Farah RJ; Stevenson PA; Gooley TA; Storb R; Scott BL
    Biol Blood Marrow Transplant; 2019 Jul; 25(7):1331-1339. PubMed ID: 30711779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and follow-up parameters in patients with paroxysmal nocturnal hemoglobinuria (PNH): experience of the Austrian PNH network.
    Füreder W; Sperr WR; Heibl S; Zebisch A; Pfeilstöcker M; Stefanzl G; Jäger E; Greiner G; Schwarzinger I; Kundi M; Keil F; Hoermann G; Bettelheim P; Valent P
    Ann Hematol; 2020 Oct; 99(10):2303-2313. PubMed ID: 32856141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria.
    Reiss UM; Schwartz J; Sakamoto KM; Puthenveetil G; Ogawa M; Bedrosian CL; Ware RE
    Pediatr Blood Cancer; 2014 Sep; 61(9):1544-50. PubMed ID: 24777716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pregnancy in paroxysmal nocturnal hemoglobinuria on long-term eculizumab.
    Vekemans MC; Lambert C; Ferrant A; Saussoy P; Havelange V; Debiève F; Van Den Neste E; Michaux L
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):464-6. PubMed ID: 25688464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab.
    Tomazos I; Sierra JR; Johnston KM; Cheung A; Brodsky RA; Weitz IC
    Hematology; 2020 Dec; 25(1):327-334. PubMed ID: 32856539
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of pregnancy and delivery in patients with paroxysmal nocturnal hemoglobinuria].
    Usuki K
    Rinsho Ketsueki; 2015 Jul; 56(7):785-94. PubMed ID: 26251141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful pregnancy and delivery achieved with eculizumab administration initiated after a preceding missed abortion in a patient with paroxysmal nocturnal hemoglobinuria].
    Tsutsui M; Gotoh A; Komatsu N
    Rinsho Ketsueki; 2019; 60(4):281-285. PubMed ID: 31068556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achievements and limitations of complement inhibition by eculizumab in paroxysmal nocturnal hemoglobinuria: the role of complement component 3.
    Risitano AM; Perna F; Selleri C
    Mini Rev Med Chem; 2011 Jun; 11(6):528-35. PubMed ID: 21561403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience.
    Czyż J; Szukalski Ł; Szukalska A; Budziszewska BK; Lech-Marańda E; Zdziarska J; Sacha T
    Adv Clin Exp Med; 2022 Jun; 31(6):707-710. PubMed ID: 35699586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
    Kulasekararaj AG; Hill A; Langemeijer S; Wells R; González Fernández FA; Gaya A; Ojeda Gutierrez E; Piatek CI; Mitchell L; Usuki K; Bosi A; Brodsky RA; Ogawa M; Yu J; Ortiz S; Röth A; Lee JW; Peffault de Latour R
    Eur J Haematol; 2021 Mar; 106(3):389-397. PubMed ID: 33301613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab.
    Kang KW; Moon H; Lee BH; Jeon MJ; Yu ES; Kim DS; Lee SR; Sung HJ; Choi CW; Kim BS; Lee J; Park Y
    Ann Hematol; 2020 Jul; 99(7):1493-1503. PubMed ID: 32542443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.